Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Transfusion and Agglutination02:45

Blood Transfusion and Agglutination

Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Blood Transfusion01:15

Blood Transfusion

Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Typing01:10

Blood Typing

Understanding an individual's blood group is a critical component of transfusion medicine. It ensures compatibility in blood transfusions, organ transplants, and even during pregnancy. Determining these blood groups involves the ABO and Rh blood typing systems, utilizing specific antigens and corresponding anti-sera to identify an individual's blood type.
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target antigens A,...
Bone Marrow Sampling and Transplants01:22

Bone Marrow Sampling and Transplants

Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...
The ABO Blood Group01:12

The ABO Blood Group

The ABO blood group system is a critical element of transfusion medicine, essential for determining blood compatibility in transfusions and organ transplants. It is based on specific antigens, or agglutinogens, present on the surface of red blood cells (RBCs) and corresponding antibodies, or agglutinins, in the blood plasma.
Antigens in the ABO Blood Group System
Antigens are substances that can trigger an immune response, leading to the production of antibodies. In the ABO blood group system,...
Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ISBT Working Party on Information Technology Guideline on external electronic communication of transfusion traceability information.

Vox sanguinis·2026
Same author

Tracing the gaps: A global snapshot.

Vox sanguinis·2026
Same author

Gene duplication is associated with gene diversification and potential neofunctionalization in lung cancer evolution.

Genome research·2026
Same author

Predicting human and viral protein variants affecting COVID-19 susceptibility and repurposing therapeutics.

Scientific reports·2024
Same author

Guidelines for the specification, implementation and management of IT systems in hospital transfusion laboratories: A British Society for Haematology Guideline.

Transfusion medicine (Oxford, England)·2024
Same author

Haemovigilance resources available for everyone: A report from the International Haemovigilance Tools Collaborative Project.

Vox sanguinis·2023

Related Experiment Video

Updated: Jun 25, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

Transfusion medicine and safety.

Roger Dodd1, W Kurt Roth, Paul Ashford

  • 1American Red Cross Holland Laboratory, 15601 Crabbs Branch Way, Rockville, MD 20855, USA. dodd@usa.redcross.org

Biologicals : Journal of the International Association of Biological Standardization
|February 24, 2009
PubMed
Summary

Blood transfusion safety has advanced through screening for infections like HBV, HCV, and HIV using immunoassays and nucleic acid tests (NAT). Current efforts focus on bacterial contamination and pathogen inactivation to ensure the safest blood supply.

Related Experiment Videos

Last Updated: Jun 25, 2026

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
05:23

Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload

Published on: March 14, 2017

Area of Science:

  • Transfusion Medicine
  • Infectious Disease Epidemiology
  • Public Health

Background:

  • Transfusion-transmitted infections (TTI) remain a primary concern in blood transfusion safety.
  • Epidemiological studies have driven the development of screening assays for viral pathogens.

Purpose of the Study:

  • To review advances in blood transfusion safety, focusing on TTI prevention.
  • To highlight the evolution of screening methods and emerging safety challenges.

Main Methods:

  • Review of epidemiological studies on TTI.
  • Description of immunoassays and nucleic acid tests (NAT) for pathogen detection.
  • Discussion of bacterial contamination and pathogen inactivation technologies.

Main Results:

  • Immunoassays and NAT have significantly reduced the transmission risk of HBV, HCV, HIV-1/2, and HTLV-I/II.
  • Nucleic acid tests (NAT) effectively reduce the risk of "window period" infections.
  • Bacterial contamination, particularly in platelet concentrates, is an emerging safety concern.

Conclusions:

  • Continued advancements in screening, pathogen inactivation, and hemovigilance are crucial for enhancing blood transfusion safety.
  • Harmonization of practices and ongoing surveillance are essential for minimizing infectious risks.
  • Future strategies aim to mitigate risks from both known and emerging infectious agents.